Contact

All Stories

  1. Finding cures for asthma: new paradigms for drug discovery and therapy

    Article • The Medical Journal of Australia, November 2025, Wiley

    Conjoint Professor Peter Wark

  2. Inhaled Ciclesonide for Community‐Based COVID‐19: A Placebo‐Controlled Randomised Trial

    Article • Respirology, October 2025, Wiley

    Conjoint Professor Peter Wark

  3. Adverse Events and Drug Interactions Associated with Elexacaftor/Tezacaftor/Ivacaftor Treatment: A Descriptive Study Across Australian, Canadian, and American Adverse Event Databases

    Article • Life, August 2025, MDPI AG

    Conjoint Professor Peter Wark

  4. Characterising airway inflammation in Aboriginal and Torres Strait Islander and non-Aboriginal and Torres Strait Islander adults with asthma and COPD

    Article • BMJ Open Respiratory Research, February 2025, BMJ

    Conjoint Professor Peter Wark

  5. Immune checkpoints are suppressed during pregnancy following influenza A virus infection

    Article • AJP Lung Cellular and Molecular Physiology, December 2024, American Physiological Society

    Conjoint Professor Peter Wark

  6. Bile acids in the lower airways is associated with airway microbiota changes in chronic obstructive pulmonary disease: an observational study

    Article • BMJ Open Respiratory Research, December 2024, BMJ

    Conjoint Professor Peter Wark

  7. Allergic broncho‐pulmonary aspergillosis: Old disease, new frontiers

    Article • Respirology, June 2024, Wiley

    Conjoint Professor Peter Wark

  8. Real-world use of inhaled corticosteroid/formoterol as needed in adults with mild asthma: the PRIME study

    Article • ERJ Open Research, May 2024, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  9. Endoplasmic reticulum stress enhances the expression of TLR3-induced TSLP by airway epithelium

    Article • AJP Lung Cellular and Molecular Physiology, May 2024, American Physiological Society

    Conjoint Professor Peter Wark

  10. Mapping the Common Barriers to Optimal COPD Care in High and Middle-Income Countries: Qualitative Perspectives from Clinicians

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2024, Taylor & Francis

    Conjoint Professor Peter Wark

  11. Biologic therapies for severe asthma with persistent type 2 inflammation

    Article • Australian Prescriber, April 2024, Therapeutic Guidelines Limited

    Conjoint Professor Peter Wark

  12. Cough in Children and Adults: Diagnosis, Assessment and Management (CICADA). Summary of an updated position statement on chronic cough in Australia

    Article • The Medical Journal of Australia, April 2024, Wiley

    Conjoint Professor Peter Wark

  13. Cough in Children and Adults: Diagnosis, Assessment and Management (CICADA). Summary of an updated position statement on chronic cough in Australia

    Article • The Medical Journal of Australia, April 2024, Wiley

    Conjoint Professor Peter Wark

  14. Large airway wall vascularity in patients with Asthma COPD overlap: a bronchoscopy study

    Article • ERJ Open Research, March 2024, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  15. Mapping the common barriers to optimal COPD care in high and middle-income countries: qualitative perspectives from clinicians

    Article • November 2023, Cold Spring Harbor Laboratory Press

    Conjoint Professor Peter Wark

  16. Inflammatory and antiviral responses to influenza A virus infection are dysregulated in pregnant mice with allergic airway disease

    Article • AJP Lung Cellular and Molecular Physiology, September 2023, American Physiological Society

    Conjoint Professor Peter Wark

  17. Upper Respiratory Tract OC43 Infection Model for Investigating Airway Immune-modifying Therapies

    Article • American Journal of Respiratory Cell and Molecular Biology, August 2023, American Thoracic Society

    Conjoint Professor Peter Wark

  18. Mechanical forces suppress antiviral innate immune responses from asthmatic airway epithelial cells following rhinovirus infection

    Article • AJP Lung Cellular and Molecular Physiology, August 2023, American Physiological Society

    Conjoint Professor Peter Wark

  19. Long-term therapy with elexacaftor/tezacaftor/ivacaftor (ETI) in cystic fibrosis: improved clinical outcomes but infection and inflammation persist

    Article • European Respiratory Journal, August 2023, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  20. Saline at lower tonicity in CF (SALTI-CF) trial comparing 0.9% v 3% v 6% nebulised saline

    Article • European Respiratory Journal, June 2023, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  21. BILE ACIDS IN LOWER AIRWAYS AS A NOVEL INDICATOR OF AIRWAY MICROBIOTA CHANGES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

    Article • June 2023, Cold Spring Harbor Laboratory Press

    Conjoint Professor Peter Wark

  22. Comparative B cell and antibody responses induced by adenoviral vectored and mRNA vaccines against COVID-19

    Article • June 2023, Cold Spring Harbor Laboratory Press

    Conjoint Professor Peter Wark

  23. Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics

    Article • Respirology, April 2023, Wiley

    Conjoint Professor Peter Wark

  24. Comparison of commercially available differentiation media on morphology, function, and virus-host interaction in conditionally reprogrammed human bronchial epithelial cells

    Article • April 2023, Cold Spring Harbor Laboratory Press

    Conjoint Professor Peter Wark

  25. A systematic review of the colorectal microbiome in adult cystic fibrosis patients

    Article • Colorectal Disease, February 2023, Wiley

    Conjoint Professor Peter Wark

  26. Probiotic Bifidobacterium longum subsp. longum Protects against Cigarette Smoke-Induced Inflammation in Mice

    Article • International Journal of Molecular Sciences, December 2022, MDPI AG

    Conjoint Professor Peter Wark

  27. Survival of people with cystic fibrosis in Australia

    Article • Scientific Reports, November 2022, Springer Science + Business Media

    Conjoint Professor Peter Wark

  28. Conditionally reprogrammed asthmatic bronchial epithelial cells express lower FOXJ1 at terminal differentiation and lower IFNs following RV-A1 infection

    Article • AJP Lung Cellular and Molecular Physiology, October 2022, American Physiological Society

    Conjoint Professor Peter Wark

  29. Obesity and COVID-19 Disease: To Inflame or Not

    Article • American Review of Respiratory Disease, September 2022, American Thoracic Society

    Conjoint Professor Peter Wark

  30. Association between dietary fibre, microbial metabolites and airway obstruction in COPD patients and murine models

    Article • September 2022, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  31. Crucial role of iron metabolism in determining outcomes of influenza A virus infection and disease

    Article • September 2022, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  32. Histone deacetylase-6 (HDAC6) promotes protective responses during murine influenza A virus (IAV) infection

    Article • September 2022, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  33. Hydrogen sulfide attenuates cigarette smoke-induced oxidative stress and inflammation in human primary bronchial epithelial cells and experimental COPD

    Article • September 2022, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  34. Relationship between interleukin-13 and transferrin receptor-1 responses in the pathogenesis of asthma

    Article • September 2022, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  35. Regional variation in prevalence of difficult-to-treat asthma and oral corticosteroid use for patients in Australia: heat map analysis

    Article • Journal of Asthma, July 2022, Taylor & Francis

    Conjoint Professor Peter Wark

  36. We need to understand why viral infections lead to acute asthma

    Article • European Respiratory Journal, July 2022, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  37. Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease

    Article • Clinical Infectious Diseases, June 2022, Oxford University Press (OUP)

    Conjoint Professor Peter Wark

  38. IL-25 blockade augments antiviral immunity during respiratory virus infection

    Article • Communications Biology, May 2022, Springer Science + Business Media

    Conjoint Professor Peter Wark, Dr Punnam Chander Veerati

  39. Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network FluCAN

    Article • Communicable Diseases Intelligence, April 2022, Australian Government Department of Health

    Conjoint Professor Peter Wark

  40. Mental health care needs in cystic fibrosis: A scoping review

    Article • Social Work in Health Care, February 2022, Taylor & Francis

    Conjoint Professor Peter Wark

  41. Understanding motivation for Australian adolescents and young adults with cystic fibrosis: Modifiable factors to support self‐management

    Article • Health & Social Care in the Community, January 2022, Hindawi Publishing Corporation

    Conjoint Professor Peter Wark

  42. Pathogenesis, clinical features of asthma COPD overlap, and therapeutic modalities

    Article • AJP Lung Cellular and Molecular Physiology, January 2022, American Physiological Society

    Conjoint Professor Peter Wark

  43. Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN)

    Article • Communicable Diseases Intelligence, January 2022, Australian Government Department of Health

    Conjoint Professor Peter Wark

  44. Factors Associated with Asthma Exacerbations During Pregnancy

    Article • The Journal of Allergy and Clinical Immunology In Practice, December 2021, Elsevier

    Conjoint Professor Peter Wark

  45. Increased cough, mucus and wheeze characterise COPD and Asthma in Australian Aboriginal adults

    Article • September 2021, European Respiratory Society (ERS)

    Nick Young, Conjoint Professor Peter Wark

  46. We are not doing enough to prevent the spread of COVID‐19 and other respiratory viruses in Australian hospitals

    Article • The Medical Journal of Australia, July 2021, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Conjoint Professor Peter Wark

  47. Transcriptomics of biopsies identifies novel genes and pathways linked to neutrophilic inflammation in severe asthma

    Article • Clinical & Experimental Allergy, July 2021, Wiley

    Conjoint Professor Peter Wark

  48. Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights

    Article • European Respiratory Journal, July 2021, European Respiratory Society (ERS)

    Dr Sukhwinder Singh Sohal, Conjoint Professor Peter Wark

  49. Dysregulated actin cytoskeleton associated with barrier dysfunction in asthma

    Article • The FASEB Journal, May 2021, Wiley

    Conjoint Professor Peter Wark

  50. Mepolizumab asthma treatment failure due to refractory airway eosinophilia, which responded to benralizumab

    Article • Respirology Case Reports, April 2021, Wiley

    Conjoint Professor Peter Wark

  51. Redesign of the Australian Cystic Fibrosis Data Registry: A multidisciplinary collaboration

    Article • Paediatric Respiratory Reviews, March 2021, Elsevier

    Conjoint Professor Peter Wark

  52. Asthma-COPD overlap: current understanding and the utility of experimental models

    Article • European Respiratory Review, February 2021, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  53. ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma

    Article • Respirology, January 2021, Wiley

    Conjoint Professor Peter Wark, Dr Punnam Chander Veerati

  54. Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections

    Article • AJP Lung Cellular and Molecular Physiology, January 2021, American Physiological Society

    Conjoint Professor Peter Wark

  55. Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma

    Article • Allergy Asthma and Immunology Research, January 2021, The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al

    Conjoint Professor Peter Wark

  56. TLR2-mediated innate immune priming boosts lung anti-viral immunity

    Article • European Respiratory Journal, December 2020, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark, Nathan Bartlett, Dr Punnam Chander Veerati

  57. Molecular and Immunological Mechanisms Underlying the Various Pharmacological Properties of the Potent Bioflavonoid, Rutin

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, December 2020, Bentham Science Publishers

    Dr Dinesh Kumar Chellappan, Dr Gaurav Gupta, Brian Oliver, Conjoint Professor Peter Wark, Dr Alan Hsu, Phil Hansbro

  58. Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells

    Article • AJP Lung Cellular and Molecular Physiology, December 2020, American Physiological Society

    Conjoint Professor Peter Wark

  59. Curcumin-loaded niosomes downregulate mRNA expression of pro-inflammatory markers involved in asthma: an in vitro study

    Article • Nanomedicine, December 2020, Future Medicine

    Conjoint Professor Peter Wark

  60. Omalizumab Is an Effective Intervention in Severe Asthma with Fungal Sensitization

    Article • The Journal of Allergy and Clinical Immunology In Practice, November 2020, Elsevier

    Conjoint Professor Peter Wark

  61. Australian cystic fibrosis community views on organoids

    Article • ERJ Open Research, October 2020, European Respiratory Society (ERS)

    Shafa Waters, Laura Fawcett, Conjoint Professor Peter Wark

  62. PAT in the ER for Transmembrane Protein Folding

    Article • Trends in Biochemical Sciences, October 2020, Elsevier

    Conjoint Professor Peter Wark

  63. Severe Nocardia pneumonia in an immunocompromised patient with alpha‐1 antitrypsin deficiency

    Article • Respirology Case Reports, September 2020, Wiley

    Conjoint Professor Peter Wark

  64. Omalizumab is an effective intervention in severe asthma with aspergillus sensitisation

    Article • September 2020, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  65. Managing T2-High Inflammation in Severe Asthma - Are Biomarkers Better Than Clinician Judgement?

    Article • September 2020, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  66. Late Breaking Abstract - ACE2 expression in lower airway epithelial cells is increased with age and in males, but is less in asthma

    Article • September 2020, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  67. ACE2 Expression is elevated in Airway Epithelial Cells from aged and male donors but reduced in asthma

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Conjoint Professor Peter Wark

  68. A Sputum 6 Gene Expression Signature Predicts Inflammatory Phenotypes and Future Exacerbations of COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2020, Taylor & Francis

    Conjoint Professor Peter Wark

  69. Molecular mechanisms of action of naringenin in chronic airway diseases

    Article • European Journal of Pharmacology, July 2020, Elsevier

    Dr Keshav Raj Paudel, Conjoint Professor Peter Wark, Dr RAJENDRA AWASTHI

  70. Celastrol-loaded liquid crystalline nanoparticles as an anti-inflammatory intervention for the treatment of asthma

    Article • International Journal of Polymeric Materials, May 2020, Taylor & Francis

    Conjoint Professor Peter Wark

  71. Asthma and the Dysregulated Immune Response to Rhinovirus

    Article • American Review of Respiratory Disease, April 2020, American Thoracic Society

    Conjoint Professor Peter Wark

  72. Management of acute COPD exacerbations in Australia: do we follow the guidelines?

    Article • ERJ Open Research, April 2020, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark, vanessa mcdonald, Dr Dimitar Sajkov

  73. A survey of specialist opinions on biomarker use in severe asthma in Australia: scepticism but hope?

    Article • ERJ Open Research, April 2020, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  74. Contemporary Concise Review 2019: Asthma

    Article • Respirology, March 2020, Wiley

    Conjoint Professor Peter Wark

  75. Diagnosis and treatment of lung disease associated with alpha one‐antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand*

    Article • Respirology, February 2020, Wiley

    Conjoint Professor Peter Wark

  76. Immunological axis of berberine in managing inflammation underlying chronic respiratory inflammatory diseases

    Article • Chemico-Biological Interactions, February 2020, Elsevier

    Conjoint Professor Peter Wark

  77. Six gene and TH2 signature expression in endobronchial biopsies of participants with asthma

    Article • Immunity Inflammation and Disease, January 2020, Wiley

    Conjoint Professor Peter Wark

  78. Sputum transcriptomics implicates increased p38 signalling activity in severe asthma

    Article • Respirology, December 2019, Wiley

    Andrew Reid, Conjoint Professor Peter Wark

  79. Targeting treatable traits in severe asthma: a randomised controlled trial

    Article • European Respiratory Journal, December 2019, European Respiratory Society (ERS)

    vanessa mcdonald, Conjoint Professor Peter Wark

  80. Antiviral immunity is impaired in COPD patients with frequent exacerbations

    Article • AJP Lung Cellular and Molecular Physiology, December 2019, American Physiological Society

    Andrew Reid, Conjoint Professor Peter Wark, Dr Punnam Chander Veerati

  81. Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease

    Article • Journal of Cystic Fibrosis, December 2019, Elsevier

    Conjoint Professor Peter Wark

  82. Preparation, characterization and in-vitro efficacy of quercetin loaded liquid crystalline nanoparticles for the treatment of asthma

    Article • Journal of Drug Delivery Science and Technology, December 2019, Elsevier

    Conjoint Professor Peter Wark

  83. Nasal epithelial cells to assess in vitro immune responses to respiratory virus infection in pregnant women with asthma

    Article • November 2019, Springer Science + Business Media

    Conjoint Professor Peter Wark

  84. Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2018: the Influenza Complications Alert Network (FluCAN)

    Article • Communicable Diseases Intelligence, November 2019, Australian Government Department of Health

    Conjoint Professor Peter Wark

  85. Blood Neutrophils In COPD But Not Asthma Exhibit A Primed Phenotype With Downregulated CD62L Expression

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2019, Taylor & Francis

    Jodie Simpson Simpson, Conjoint Professor Peter Wark

  86. Hypoxia‐inducible factor and bacterial infections in chronic obstructive pulmonary disease

    Article • Respirology, October 2019, Wiley

    Conjoint Professor Peter Wark

  87. People with asthma are more likely to become ill from influenza

    Article • European Respiratory Journal, October 2019, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  88. A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis

    Article • September 2019, European Respiratory Society (ERS)

    Koliarne Tong, Conjoint Professor Peter Wark

  89. Asthmatic airway epithelial cells subjected to apical mechanical stress exhibit suppressed interferon release following viral infection

    Article • September 2019, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  90. Circulatory neutrophils in COPD feature downregulated CD62L expression in comparison with asthma and healthy participants

    Article • September 2019, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  91. Inhibition of ER stress suppresses IL-13 induced airway epithelial remodeling

    Article • September 2019, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  92. Endobronchial biopsy gene expression between different severe asthma inflammatory phenotypes

    Article • September 2019, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  93. Treatment with Omalizumab in adults with severe allergic reduces Fc?I expression on dendritic cells and improves antiviral responses

    Article • September 2019, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  94. Sputum gene signature comparison study between U-BIOPRED and Australia asthma cohorts

    Article • September 2019, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  95. Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2017: the Influenza Complications Alert Network (FluCAN)

    Article • Communicable Diseases Intelligence, September 2019, Australian Government Department of Health

    Conjoint Professor Peter Wark

  96. Fibulin-1c regulates transforming growth factor–β activation in pulmonary tissue fibrosis

    Article • JCI Insight, August 2019, American Society for Clinical Investigation

    Conjoint Professor Peter Wark

  97. RIPLET, and not TRIM25, is required for endogenous RIG‐I‐dependent antiviral responses

    Article • Immunology and Cell Biology, August 2019, Wiley

    Conjoint Professor Peter Wark

  98. Respiratory syncytial virus co-opts host mitochondrial function to favour infectious virus production

    Article • eLife, June 2019, eLife

    Conjoint Professor Peter Wark

  99. Lumacaftor/ Ivacaftor improves exercise tolerance in patients with Cystic Fibrosis and severe airflow obstruction

    Article • BMC Pulmonary Medicine, June 2019, Springer Science + Business Media

    Conjoint Professor Peter Wark

  100. IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis

    Article • European Respiratory Journal, June 2019, European Respiratory Society (ERS)

    Mr Guy John-Malcolm Cameron, Conjoint Professor Peter Wark

  101. Platelet activating factor receptor regulates colitis-induced pulmonary inflammation through the NLRP3 inflammasome

    Article • Mucosal Immunology, April 2019, Springer Science + Business Media

    Conjoint Professor Peter Wark

  102. Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report

    Article • European Respiratory Journal, March 2019, European Respiratory Society (ERS)

    vanessa mcdonald, James Fingleton, Conjoint Professor Peter Wark

  103. The importance of acute asthma.

    Article • American Review of Respiratory Disease, February 2019, American Thoracic Society

    Conjoint Professor Peter Wark

  104. CSF3R/CD114 mediates infection-dependent transition to severe asthma

    Article • Journal of Allergy and Clinical Immunology, February 2019, Elsevier

    Conjoint Professor Peter Wark

  105. Hypersegmented airway neutrophils and its association with reduced lung function in adults with obstructive airway disease: an exploratory study

    Article • BMJ Open, January 2019, BMJ

    Conjoint Professor Peter Wark

  106. Molecular modulators of celastrol as the keystones for its diverse pharmacological activities

    Article • Biomedicine & Pharmacotherapy, January 2019, Elsevier

    Conjoint Professor Peter Wark

  107. Enhancing tristetraprolin activity reduces the severity of cigarette smoke‐induced experimental chronic obstructive pulmonary disease

    Article • Clinical & Translational Immunology, January 2019, Wiley

    Conjoint Professor Peter Wark

  108. The interplay of the host, virus, and the environment

    Article • January 2019, Elsevier

    Conjoint Professor Peter Wark

  109. Assessing the potential of liposomes loaded with curcumin as a therapeutic intervention in asthma

    Article • Colloids and Surfaces B Biointerfaces, December 2018, Elsevier

    Conjoint Professor Peter Wark

  110. Multi-Centre Ethics and Research Governance Review Can Impede Non-Interventional Clinical Research

    Article • Internal Medicine Journal, November 2018, Wiley

    Professor Rachel M Thomson, Conjoint Professor Peter Wark

  111. Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease

    Article • Journal of Leukocyte Biology, September 2018, Wiley

    Mr Guy John-Malcolm Cameron, Conjoint Professor Peter Wark

  112. Nebulised hypertonic saline for cystic fibrosis

    Article • Cochrane Database of Systematic Reviews, September 2018, Wiley

    Conjoint Professor Peter Wark

  113. Treatable traits can be identified in a severe asthma registry and predict future exacerbations

    Article • Respirology, September 2018, Wiley

    Conjoint Professor Peter Wark

  114. Mechanisms of impaired anti-bacterial Th1 responses in patients with chronic obstructive pulmonary disease

    Article • September 2018, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  115. Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors

    Article • September 2018, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  116. Influenza Epidemiology, Vaccine Coverage and Vaccine Effectiveness in Children Admitted to Sentinel Australian Hospitals in 2017: Results from the PAEDS-FluCAN Collaboration

    Article • Clinical Infectious Diseases, August 2018, Oxford University Press (OUP)

    Conjoint Professor Peter Wark

  117. Influenza A virus infection dysregulates the expression of microRNA-22 and its targets; CD147 and HDAC4, in epithelium of asthmatics

    Article • August 2018, Springer Science + Business Media

    Conjoint Professor Peter Wark

  118. Appropriate use of oral corticosteroids for severe asthma

    Article • The Medical Journal of Australia, July 2018, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Conjoint Professor Peter Wark

  119. Effects of fruit and vegetable consumption on inflammatory biomarkers and immune cell populations: a systematic literature review and meta-analysis

    Article • American Journal of Clinical Nutrition, July 2018, Elsevier

    Conjoint Professor Peter Wark

  120. Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations

    Article • Nature Communications, June 2018, Springer Science + Business Media

    Andrew Reid, Conjoint Professor Peter Wark, Dr Punnam Chander Veerati

  121. Trends in asthma self-management skills and inhaled corticosteroid use during pregnancy and postpartum from 2004 to 2017

    Article • Journal of Asthma, May 2018, Taylor & Francis

    Conjoint Professor Peter Wark

  122. Persistent induction of goblet cell differentiation in the airways: Therapeutic approaches

    Article • Pharmacology & Therapeutics, May 2018, Elsevier

    Andrew Reid, Conjoint Professor Peter Wark, Dr Punnam Chander Veerati

  123. Developments in cystic fibrosis personalised epithelial assays: Science and patient perspectives

    Article • Journal of Cystic Fibrosis, May 2018, Elsevier

    Conjoint Professor Peter Wark

  124. Pseudomonas pharyngitis in a cystic fibrosis patient

    Article • Respirology Case Reports, April 2018, Wiley

    Conjoint Professor Peter Wark

  125. Immunological axis of curcumin-loaded vesicular drug delivery systems

    Article • Future Medicinal Chemistry, April 2018, Future Science

    Dr Gaurav Gupta, Conjoint Professor Peter Wark

  126. Impaired Th1 responses in patients with acute exacerbations of COPD are improved with PD-1 blockade

    Article • Clinical Immunology, March 2018, Elsevier

    Conjoint Professor Peter Wark

  127. Understanding the Unfolded Protein Response in the Pathogenesis of Asthma

    Article • Frontiers in Immunology, February 2018, Frontiers

    Conjoint Professor Peter Wark

  128. Respiratory Viruses and Asthma

    Article • Seminars in Respiratory and Critical Care Medicine, February 2018, Thieme Publishing Group

    Conjoint Professor Peter Wark

  129. Eosinophilia as a treatable trait in three patients with asthma and COPD

    Article • Respirology Case Reports, January 2018, Wiley

    Conjoint Professor Peter Wark

  130. Pathophysiology of severe asthma: We’ve only just started

    Article • Respirology, January 2018, Wiley

    Conjoint Professor Peter Wark

  131. Systematic review and website presentation of validated dietary assessment tools

    Article • Proceedings of The Nutrition Society, January 2018, Cambridge University Press

    Conjoint Professor Peter Wark

  132. Airway remodelling and inflammation in asthma are dependent on the extracellular matrix protein fibulin-1c

    Article • The Journal of Pathology, November 2017, Wiley

    Dr Jane E Bourke, Gang Liu, Brian Oliver, Conjoint Professor Peter Wark

  133. ENHANCED CD147 EXPRESSION AFTER H1N1 INFECTION; A POTENTIAL MECHANISM FOR AIRWAY EPITHELIUM IMPAIRMENT IN ASTHMA

    Article • Respirology, November 2017, Wiley

    Conjoint Professor Peter Wark

  134. SPUTUM 6 GENE EXPRESSION SIGNATURE PREDICTS INFLAMMATORY PHENOTYPE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    Article • Respirology, November 2017, Wiley

    Conjoint Professor Peter Wark

  135. A new website to support dietary assessment in health research: Nutritools.org

    Article • European Journal of Public Health, October 2017, Oxford University Press (OUP)

    Conjoint Professor Peter Wark

  136. Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2017, Dove Medical Press

    Netsanet Negewo, vanessa mcdonald, Jodie Simpson Simpson, Conjoint Professor Peter Wark

  137. Multidimensional assessment and targeted therapy of severe asthma: a randomised controlled trial (RCT)

    Article • September 2017, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  138. A transcriptomic comparison between nasal and bronchial airway epithelia from children

    Article • September 2017, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  139. Regulation of xanthine dehydrogensase gene expression and uric acid production in human airway epithelial cells

    Article • PLOS One, September 2017, PLOS

    Conjoint Professor Peter Wark

  140. Role for NLRP3 Inflammasome–mediated, IL-1β–Dependent Responses in Severe, Steroid-Resistant Asthma

    Article • American Review of Respiratory Disease, August 2017, American Thoracic Society

    Phil Hansbro, Conjoint Professor Peter Wark

  141. MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD

    Article • JCI Insight, April 2017, American Society for Clinical Investigation

    Conjoint Professor Peter Wark

  142. Effects of Fruit and Vegetable Consumption on Risk of Asthma, Wheezing and Immune Responses: A Systematic Review and Meta-Analysis

    Article • Nutrients, March 2017, MDPI AG

    Conjoint Professor Peter Wark

  143. Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling

    Article • eLife, February 2017, eLife

    Conjoint Professor Peter Wark

  144. Role of miR-218 in COPD

    Article • American Review of Respiratory Disease, January 2017, American Thoracic Society

    Dr Alan Hsu, Prof. Dr. Ken R Bracke, Conjoint Professor Peter Wark

  145. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)

    Article • The Lancet Respiratory Medicine, January 2017, Elsevier

    Conjoint Professor Peter Wark, Professor Marek Sanak

  146. Use of biologics to treat acute exacerbations and manage disease in asthma, COPD and IPF

    Article • Pharmacology & Therapeutics, January 2017, Elsevier

    Conjoint Professor Peter Wark

  147. Severe asthma: Current management, targeted therapies and future directions-A roundtable report

    Article • Respirology, November 2016, Wiley

    vanessa mcdonald, Conjoint Professor Peter Wark

  148. Acute myocardial infarction in disseminated mucormycosis infection

    Article • European Heart Journal, November 2016, European Society of Cardiology

    Conjoint Professor Peter Wark

  149. The genetic and epigenetic landscapes of the epithelium in asthma

    Article • September 2016, Springer Science + Business Media

    Dr Alan Hsu, Andrew Reid, Conjoint Professor Peter Wark

  150. A treatment algorithm adjusting oral corticosteroid using blood eosinophils reduces exacerbations and improves asthma control, in difficult asthmatics

    Article • European Respiratory Journal, September 2016, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  151. Effect of oxidative stress and rhinovirus infection on mitochondrial/endoplasmic reticular function in human primary bronchial epithelial cells

    Article • European Respiratory Journal, September 2016, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  152. Micro-RNA-125a/b target A20 and MAVS to promote inflammatory and impair antiviral responses in chronic obstructive pulmonary disease

    Article • European Respiratory Journal, September 2016, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  153. NLRP3 inflammasome-mediated, IL-1β-dependent inflammatory responses drive steroid-resistant asthma

    Article • European Respiratory Journal, September 2016, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  154. Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

    Article • Internal Medicine Journal, September 2016, Wiley

    Conjoint Professor Peter Wark

  155. Recent advances in understanding and managing asthma

    Article • F1000Research, August 2016, Faculty of 1000, Ltd.

    Conjoint Professor Peter Wark

  156. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2016, Dove Medical Press

    Netsanet Negewo, vanessa mcdonald, Jodie Simpson Simpson, Conjoint Professor Peter Wark

  157. Impaired Antiviral Stress Granule and IFN-β Enhanceosome Formation Enhances Susceptibility to Influenza Infection in Chronic Obstructive Pulmonary Disease Epithelium

    Article • American Journal of Respiratory Cell and Molecular Biology, July 2016, American Thoracic Society

    Dr Alan Hsu, Conjoint Professor Peter Wark

  158. What is asthma−COPD overlap syndrome? Towards a consensus definition from a round table discussion

    Article • European Respiratory Journal, June 2016, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  159. Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases

    Article • JCI Insight, June 2016, American Society for Clinical Investigation

    Brian Oliver, Conjoint Professor Peter Wark

  160. Advances in the treatment of virus-induced asthma

    Article • Expert Review of Respiratory Medicine, May 2016, Taylor & Francis

    Conjoint Professor Peter Wark

  161. Acute oxygen therapy: a review of prescribing and delivery practices

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2016, Dove Medical Press

    Ms Joyce L Cousins, vanessa mcdonald, Conjoint Professor Peter Wark

  162. Targeted therapeutics for severe refractory asthma: monoclonal antibodies

    Article • Expert Review of Clinical Pharmacology, April 2016, Taylor & Francis

    Conjoint Professor Peter Wark

  163. Diagnosis and investigation in the severe asthma clinic

    Article • Expert Review of Respiratory Medicine, March 2016, Taylor & Francis

    Conjoint Professor Peter Wark

  164. A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis

    Article • Thorax, January 2016, BMJ

    Dr Christopher J Harmer, Conjoint Professor Peter Wark

  165. Innate Immunity and Immune Evasion by Enterovirus 71

    Article • Viruses, December 2015, MDPI AG

    Dr Alan Hsu, Conjoint Professor Peter Wark

  166. Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014

    Article • Vaccine, December 2015, Elsevier

    Dr Tony Korman, Conjoint Professor Peter Wark

  167. A pathogenic role for tumor necrosis factor-related apoptosis-inducing ligand in chronic obstructive pulmonary disease

    Article • Mucosal Immunology, November 2015, Nature

    Dr Alan Hsu, Conjoint Professor Peter Wark

  168. Can blood eosinophils predict sputum eosinophils in stable COPD?

    Article • September 2015, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  169. Potential role of SPARC, a downstream mediator of TGF-b in chronic airways disease

    Article • September 2015, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  170. Adjusting prednisone using blood eosinophils reduces exacerbations and improves asthma control in difficult patients with asthma

    Article • Respirology, August 2015, Wiley

    Conjoint Professor Peter Wark

  171. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis

    Article • The Lancet Respiratory Medicine, August 2015, Elsevier

    Conjoint Professor Peter Wark

  172. Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia

    Article • Thorax, June 2015, BMJ

    Conjoint Professor Peter Wark

  173. Targeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease

    Article • American Review of Respiratory Disease, May 2015, American Thoracic Society

    Dr Alan Hsu, Conjoint Professor Peter Wark

  174. The Placental Protein Syncytin-1 Impairs Antiviral Responses and Exaggerates Inflammatory Responses to Influenza

    Article • PLOS One, April 2015, PLOS

    Conjoint Professor Peter Wark

  175. CD8 T cells and dendritic cells: key players in the attenuated maternal immune response to influenza infection

    Article • Journal of Reproductive Immunology, February 2015, Elsevier

    Conjoint Professor Peter Wark

  176. World alliance against antibiotic resistance: The WAAAR declaration against antibiotic resistance

    Article • Medicina Intensiva, January 2015, Elsevier

    Dr Li Yang Hsu, Conjoint Professor Peter Wark

  177. Airwayβ-Defensin-1 Protein Is Elevated in COPD and Severe Asthma

    Article • Mediators of Inflammation, January 2015, Hindawi Publishing Corporation

    Conjoint Professor Peter Wark

  178. 81

    Article • Cytokine, November 2014, Elsevier

    Conjoint Professor Peter Wark

  179. 82

    Article • Cytokine, November 2014, Elsevier

    Conjoint Professor Peter Wark

  180. 175

    Article • Cytokine, November 2014, Elsevier

    Conjoint Professor Peter Wark

  181. 147

    Article • Cytokine, November 2014, Elsevier

    Conjoint Professor Peter Wark

  182. Differential injurious effects of ambient and traffic-derived particulate matter on airway epithelial cells

    Article • Respirology, September 2014, Wiley

    Conjoint Professor Peter Wark

  183. How the placenta makes pregnant women vulnerable to influenza (Flu)

    Article • Placenta, September 2014, Elsevier

    Conjoint Professor Peter Wark

  184. PP38 Development of a new UK food composition database

    Article • Journal of Epidemiology & Community Health, September 2014, BMJ

    Conjoint Professor Peter Wark

  185. The Effect of Inhaled IFN-β on Worsening of Asthma Symptoms Caused by Viral Infections. A Randomized Trial

    Article • American Review of Respiratory Disease, July 2014, American Thoracic Society

    Conjoint Professor Peter Wark

  186. Cough Formation in Viral Infections in Children

    Article • June 2014, Taylor & Francis

    Conjoint Professor Peter Wark

  187. The interaction between mother and fetus and the development of allergic asthma

    Article • Expert Review of Respiratory Medicine, January 2014, Taylor & Francis

    Conjoint Professor Peter Wark

  188. TLR3 and MDA5 signalling, although not expression, is impaired in asthmatic epithelial cells in response to rhinovirus infection.

    Article • Clinical & Experimental Allergy, December 2013, Wiley

    Dr Alan Hsu, Conjoint Professor Peter Wark

  189. A Prospective Study of Respiratory Viral Infection in Pregnant Women With and Without Asthma

    Article • CHEST Journal, August 2013, Elsevier

    Conjoint Professor Peter Wark

  190. Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission

    Article • Respirology, July 2013, Wiley

    Conjoint Professor Peter Wark

  191. Influenza Vaccine Effectiveness against Hospitalisation with Confirmed Influenza in the 2010–11 Seasons: A Test-negative Observational Study

    Article • PLOS One, July 2013, PLOS

    Dr Tony Korman, Conjoint Professor Peter Wark

  192. Plasmacytoid Dendritic Cells and CD8 T Cells From Pregnant Women Show Altered Phenotype and Function Following H1N1/09 Infection

    Article • The Journal of Infectious Diseases, July 2013, Oxford University Press (OUP)

    Conjoint Professor Peter Wark

  193. Alterations in inflammatory, antiviral and regulatory cytokine responses in peripheral blood mononuclear cells from pregnant women with asthma

    Article • Respirology, June 2013, Wiley

    Conjoint Professor Peter Wark

  194. Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease

    Article • Rheumatology International, May 2013, Springer Science + Business Media

    Conjoint Professor Peter Wark

  195. A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis

    Article • Journal of Allergy and Clinical Immunology, March 2013, Elsevier

    Brian Oliver, Conjoint Professor Peter Wark

  196. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity

    Article • Nature Reports Stem Cells, January 2013, Springer Science + Business Media

    Conjoint Professor Peter Wark

  197. Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD

    Article • BMJ Open Respiratory Research, January 2013, Springer Science + Business Media

    Dr Alan Hsu, Conjoint Professor Peter Wark

  198. Deficient antiviral responses to influenza in primary bronchial epithelial cells of chronic obstructive pulmonary disease

    Article • Frontiers in Immunology, January 2013, Frontiers

    Conjoint Professor Peter Wark

  199. Innate immunity to influenza in chronic airways diseases

    Article • Respirology, October 2012, Wiley

    Conjoint Professor Peter Wark

  200. RAGE: a new frontier in chronic airways disease

    Article • British Journal of Pharmacology, October 2012, Wiley

    Conjoint Professor Peter Wark

  201. SharedPseudomonas aeruginosagenotypes are common in Australian cystic fibrosis centres

    Article • European Respiratory Journal, August 2012, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  202. Viral infections trigger exacerbations of cystic fibrosis in adults and children: Figure 1–

    Article • European Respiratory Journal, July 2012, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  203. Pregnant Women Have Attenuated Innate Interferon Responses to 2009 Pandemic Influenza A Virus Subtype H1N1

    Article • The Journal of Infectious Diseases, June 2012, Oxford University Press (OUP)

    Conjoint Professor Peter Wark

  204. Characteristics of a Widespread Community Cluster of H275Y Oseltamivir-Resistant A(H1N1)pdm09 Influenza in Australia

    Article • The Journal of Infectious Diseases, May 2012, Oxford University Press (OUP)

    Conjoint Professor Peter Wark

  205. Multicentre audit of inpatient management of acute exacerbations of chronic obstructive pulmonary disease: comparison with clinical guidelines

    Article • Internal Medicine Journal, April 2012, Wiley

    Conjoint Professor Peter Wark

  206. Airway inflammation in asthma, a single measurement is not enough

    Article • Respirology, March 2012, Wiley

    Conjoint Professor Peter Wark

  207. Glucocorticosteroids Differentially Regulate MMP-9 and Neutrophil Elastase in COPD

    Article • PLOS One, March 2012, PLOS

    Conjoint Professor Peter Wark

  208. Critical Role of Constitutive Type I Interferon Response in Bronchial Epithelial Cell to Influenza Infection

    Article • PLOS One, March 2012, PLOS

    Dr Alan Hsu, Conjoint Professor Peter Wark

  209. Serum amyloid A opposes lipoxin A 4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease

    Article • Proceedings of the National Academy of Sciences, January 2012, Proceedings of the National Academy of Sciences

    Conjoint Professor Peter Wark

  210. Clinical and physiological features of postinfectious chronic cough associated with H1N1 infection

    Article • Respiratory Medicine, January 2012, Elsevier

    Dr Nicole M. Ryan, Conjoint Professor Peter Wark

  211. Developments in the field of allergy in 2010 through the eyes of Clinical and Experimental Allergy

    Article • Clinical & Experimental Allergy, November 2011, Wiley

    Conjoint Professor Peter Wark

  212. Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative case control study

    Article • Vaccine, October 2011, Elsevier

    Dr Tony Korman, Conjoint Professor Peter Wark

  213. Soluble RAGE is deficient in neutrophilic asthma and COPD

    Article • European Respiratory Journal, September 2011, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  214. Impaired type I and III interferon response to rhinovirus infection during pregnancy and asthma

    Article • Thorax, September 2011, BMJ

    Conjoint Professor Peter Wark

  215. P2-316 Adult height in relation to cancer mortality in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

    Article • Journal of Epidemiology & Community Health, August 2011, BMJ

    Conjoint Professor Peter Wark

  216. Tiotropium reduced exacerbations more than salmeterol in moderate-to-very severe COPD

    Article • Annals of Internal Medicine, July 2011, American College of Physicians

    Conjoint Professor Peter Wark

  217. Human Influenza Is More Effective than Avian Influenza at Antiviral Suppression in Airway Cells

    Article • American Journal of Respiratory Cell and Molecular Biology, June 2011, American Thoracic Society

    Dr Alan Hsu, Conjoint Professor Peter Wark

  218. A Novel E3 Ubiquitin Ligase Links Rhinovirus Infection To Exacerbation Of Asthma

    Article • May 2011, American Thoracic Society

    Conjoint Professor Peter Wark

  219. Respiratory Examination

    Article • March 2011, World Scientific Pub Co Pte Lt

    Conjoint Professor Peter Wark

  220. Characterization of innate immune signalling receptors in virus-induced acute asthma

    Article • Clinical & Experimental Allergy, December 2010, Wiley

    Conjoint Professor Peter Wark

  221. Antioxidant and Anti-Inflammatory Effects of Resveratrol in Airway Disease

    Article • Antioxidants & Redox Signaling, November 2010, Mary Ann Liebert Inc

    Conjoint Professor Peter Wark

  222. Down-titration from high-dose combination therapy in asthma: Removal of long-acting β2-agonist

    Article • Respiratory Medicine, August 2010, Elsevier

    Conjoint Professor Peter Wark

  223. Viral and bacterial interactions in pneumonia

    Article • Expert Review of Respiratory Medicine, April 2010, Taylor & Francis

    Conjoint Professor Peter Wark

  224. TLR5 is not required for flagellin-mediated exacerbation of DSS colitis

    Article • Inflammatory Bowel Diseases, March 2010, Oxford University Press (OUP)

    Conjoint Professor Peter Wark

  225. Asthma during pregnancy alters immune cell profile and airway epithelial chemokine release

    Article • Inflammation Research, October 2009, Springer Science + Business Media

    Conjoint Professor Peter Wark

  226. Lycopene enrichment of cultured airway epithelial cells decreases the inflammation induced by rhinovirus infection and lipopolysaccharide

    Article • The Journal of Nutritional Biochemistry, August 2009, Elsevier

    Conjoint Professor Peter Wark

  227. Nebulised hypertonic saline for cystic fibrosis

    Article • Cochrane Database of Systematic Reviews, April 2009, Wiley

    Conjoint Professor Peter Wark

  228. Low Rates of Pseudomonas aeruginosa Misidentification in Isolates from Cystic Fibrosis Patients

    Article • Journal of Clinical Microbiology, March 2009, ASM Journals

    Conjoint Professor Peter Wark

  229. Diversity in the bronchial epithelial cell response to infection with different rhinovirus strains

    Article • Respirology, March 2009, Wiley

    Conjoint Professor Peter Wark

  230. Pathogenesis of ABPA

    Article • January 2009, Springer Science + Business Media

    Conjoint Professor Peter Wark

  231. Guest Editorial

    Article • Paediatric Respiratory Reviews, December 2008, Elsevier

    Conjoint Professor Peter Wark

  232. Innate immune response to viral infection of the lungs

    Article • Paediatric Respiratory Reviews, December 2008, Elsevier

    Conjoint Professor Peter Wark

  233. Flagellin exacerbates DSS induced Colitis via TLR5 independent mechanisms

    Article • Inflammatory Bowel Diseases, December 2008, Oxford University Press (OUP)

    Conjoint Professor Peter Wark

  234. SUPPLEMENTATION OF LONG CHAIN N-3 POLYUNSATURATED FATTY ACIDS INCREASES THE UTILIZATION OF LYCOPENE IN CULTURED AIRWAY EPITHELIAL CELLS

    Article • Journal of Food Lipids, October 2008, Wiley

    Conjoint Professor Peter Wark

  235. Anti-inflammatory effects of long-chain n-3 PUFA in rhinovirus-infected cultured airway epithelial cells

    Article • British Journal Of Nutrition, July 2008, Cambridge University Press

    Conjoint Professor Peter Wark

  236. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii

    Article • British Journal Of Nutrition, July 2008, Cambridge University Press

    Conjoint Professor Peter Wark

  237. Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages

    Article • Thorax, June 2008, BMJ

    Brian Oliver, Conjoint Professor Peter Wark

  238. The role of exhaled nitric oxide and exhaled breath condensates in evaluating airway inflammation in asthma

    Article • Expert Opinion on Medical Diagnostics, June 2008, Informa Healthcare

    Conjoint Professor Peter Wark

  239. Understanding the mechanisms of viral induced asthma: New therapeutic directions

    Article • Pharmacology & Therapeutics, March 2008, Elsevier

    Conjoint Professor Peter Wark

  240. Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease

    Article • Nature Reports Stem Cells, October 2007, Springer Science + Business Media

    Conjoint Professor Peter Wark

  241. IFN-γ–induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations

    Article • Journal of Allergy and Clinical Immunology, September 2007, Elsevier

    Conjoint Professor Peter Wark

  242. Asthma exacerbations {middle dot} 3: Pathogenesis

    Article • Thorax, October 2006, BMJ

    Conjoint Professor Peter Wark

  243. Role of deficient type III interferon-λ production in asthma exacerbations

    Article • Nature Reports Stem Cells, August 2006, Springer Science + Business Media

    Conjoint Professor Peter Wark

  244. Nebulised hypertonic saline for cystic fibrosis

    Article • July 2005, Wiley

    Conjoint Professor Peter Wark

  245. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus

    Article • Journal of Experimental Medicine, March 2005, Rockefeller University Press

    Conjoint Professor Peter Wark

  246. Induced Sputum 8-Isoprostane Concentrations in Inflammatory Airway Diseases

    Article • American Review of Respiratory Disease, March 2005, American Thoracic Society

    Conjoint Professor Peter Wark

  247. Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment

    Article • Respiratory Medicine, October 2004, Elsevier

    Conjoint Professor Peter Wark

  248. Hyperkalaemic ascending paralysis

    Article • Journal of the Royal Society of Medicine, June 2004, SAGE Publications

    Conjoint Professor Peter Wark

  249. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: A randomized controlled trial

    Article • Journal of Allergy and Clinical Immunology, May 2003, Elsevier

    Conjoint Professor Peter Wark

  250. Use of induced sputum for the diagnosis of influenza and infections in asthma: a comparison of diagnostic techniques

    Article • Journal of Clinical Virology, April 2003, Elsevier

    Conjoint Professor Peter Wark

  251. Airway inflammation in thunderstorm asthma

    Article • Clinical & Experimental Allergy, December 2002, Wiley

    Conjoint Professor Peter Wark

  252. Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma

    Article • European Respiratory Journal, October 2002, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  253. Optimization of sputum-processing methods for the measurement of interleukin-5: Effects of protease inhibition

    Article • Respirology, June 2002, Wiley

    Conjoint Professor Peter Wark

  254. Non-invasive ventilation in acute respiratory failure

    Article • Thorax, March 2002, BMJ

    Conjoint Professor Peter Wark

  255. Safety of sputum induction with isotonic saline in adults with acute severe asthma

    Article • Clinical & Experimental Allergy, November 2001, Wiley

    Conjoint Professor Peter Wark

  256. Allergic bronchopulmonary aspergillosis: New concepts of pathogenesis and treatment

    Article • Respirology, March 2001, Wiley

    Conjoint Professor Peter Wark

  257. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma

    Article • European Respiratory Journal, January 2001, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  258. Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis

    Article • European Respiratory Journal, December 2000, European Respiratory Society (ERS)

    Conjoint Professor Peter Wark

  259. Induced sputum eosinophils in the assessment of asthma and chronic cough*

    Article • Respirology, March 2000, Wiley

    Conjoint Professor Peter Wark

  260. Bronchitis

    Article • Boston Medical and Surgical Journal, April 1846, New England Journal of Medicine (NEJM/MMS)

    Conjoint Professor Peter Wark

  261. Difficult Asthma

    Article • Wiley

    Conjoint Professor Peter Wark

  262. Non-Invasive Ventilation in Acute Respiratory Failure

    Article • Wiley

    Conjoint Professor Peter Wark